Active Ingredient History
| Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
|---|
| Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
|---|
Alzheimer Disease (Phase 2)
Cognition Disorders (Phase 2)
Cognitive Dysfunction (Phase 2)
Coronavirus Infections (Phase 2/Phase 3)
Dementia, Vascular (Phase 2)
Lewy Body Disease (Phase 2)
Neurocognitive Disorders (Phase 2)
Neurodegenerative Diseases (Phase 2)
SARS-CoV-2 (Phase 2/Phase 3)
Severe Acute Respiratory Syndrome (Phase 3)
Tauopathies (Phase 2)
| Trial | Phase | Start Date | Organizations | Indications |
|---|
Feedback
Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).
Report issue